BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation
BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the European Respiratory Society International Congress 2022
Potential Oil & Gas Drilling Contractors Assess Drill Sites with Enercam Management on Block VIII, Cambodia
Corcel Drills Cu-Au Skarn, Indications of Nearby Porphyry Cu-Au Center at the Yuma King Project, Arizona
RETRANSMISSION: QIMC Reports Record 23.5% Natural Hydrogen Within the First 300 Metres of Ongoing DDH-26-05 and Observations Consistent with Free Gas at Bennett Hill at 164 Metres
